U.S. Physical Therapy, Inc. (NYSE:USPH – Get Free Report) COO Graham D. Reeve sold 1,724 shares of the business’s stock in a transaction on Friday, November 8th. The stock was sold at an average price of $96.29, for a total value of $166,003.96. Following the completion of the transaction, the chief operating officer now owns 7,106 shares of the company’s stock, valued at $684,236.74. This represents a 19.52 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.
U.S. Physical Therapy Stock Down 1.8 %
U.S. Physical Therapy stock opened at $90.18 on Friday. The stock has a fifty day moving average of $84.09 and a 200 day moving average of $91.25. U.S. Physical Therapy, Inc. has a one year low of $76.18 and a one year high of $113.63. The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.88 and a current ratio of 1.78. The stock has a market cap of $1.36 billion, a PE ratio of 95.94, a price-to-earnings-growth ratio of 4.15 and a beta of 1.38.
U.S. Physical Therapy (NYSE:USPH – Get Free Report) last released its quarterly earnings results on Tuesday, August 13th. The company reported $0.73 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.82 by ($0.09). U.S. Physical Therapy had a net margin of 3.54% and a return on equity of 8.11%. The company had revenue of $167.19 million for the quarter, compared to the consensus estimate of $163.34 million. During the same period in the prior year, the firm posted $0.76 EPS. The business’s revenue for the quarter was up 10.4% on a year-over-year basis. As a group, sell-side analysts predict that U.S. Physical Therapy, Inc. will post 2.67 EPS for the current year.
U.S. Physical Therapy Dividend Announcement
Analyst Ratings Changes
USPH has been the subject of a number of research reports. Barrington Research reiterated an “outperform” rating and set a $108.00 price objective on shares of U.S. Physical Therapy in a research report on Thursday, November 7th. Bank of America reiterated a “neutral” rating and set a $90.00 price objective (down previously from $114.00) on shares of U.S. Physical Therapy in a research report on Monday, October 7th. Finally, StockNews.com upgraded U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research report on Wednesday, August 21st.
Read Our Latest Stock Analysis on U.S. Physical Therapy
Institutional Trading of U.S. Physical Therapy
Several hedge funds have recently bought and sold shares of the stock. Rockefeller Capital Management L.P. grew its holdings in U.S. Physical Therapy by 18.8% during the third quarter. Rockefeller Capital Management L.P. now owns 160,441 shares of the company’s stock valued at $13,578,000 after purchasing an additional 25,393 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank grew its holdings in U.S. Physical Therapy by 57.1% during the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,631 shares of the company’s stock valued at $223,000 after purchasing an additional 956 shares during the period. BNP Paribas Financial Markets grew its holdings in U.S. Physical Therapy by 283.0% during the third quarter. BNP Paribas Financial Markets now owns 16,842 shares of the company’s stock valued at $1,425,000 after purchasing an additional 12,445 shares during the period. Quantbot Technologies LP boosted its stake in shares of U.S. Physical Therapy by 57.6% in the third quarter. Quantbot Technologies LP now owns 10,876 shares of the company’s stock worth $920,000 after acquiring an additional 3,973 shares during the period. Finally, Intech Investment Management LLC bought a new position in shares of U.S. Physical Therapy in the third quarter worth about $356,000.
About U.S. Physical Therapy
U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.
See Also
- Five stocks we like better than U.S. Physical Therapy
- Investing in Commodities: What Are They? How to Invest in Them
- 3 Stocks Near 52-Week Lows That Could Be Top Buys Right Now
- Airline Stocks – Top Airline Stocks to Buy Now
- 3 GARP Stocks Offering Strong Growth: Aptiv, Allstate, Barrick
- How to Use the MarketBeat Excel Dividend Calculator
- Mouse Rising: The Iger Investment Pays Off for Disney Investors
Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.